Patents by Inventor Chris Prince

Chris Prince has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230203468
    Abstract: Provided are modified isolated ADAM10 modulating peptides and methods of using the same to modulate ADAM10 biological activities, inhibit ADAM10 biological activities associated with diseases, disorders, or conditions in subjects, including but not limited to decreasing inflammation and inhibiting undesirablecell proliferation. In some embodiments, the modified isolated ADAM10 modulating peptides are based on SEQ ID NO: 3 or SEQ ID NO: 4, and in some embodiments include modifications at or near the N-terminal and/or the C-terminal ends of the disclosed peptides as well as substitutions, insertions, and deletions at one or more amino acid positions of the ADAM10 prodomain peptides disclosed herein.
    Type: Application
    Filed: May 19, 2022
    Publication date: June 29, 2023
    Inventors: Marcia L. Moss, Robert Rasmussen, Chris Prince
  • Publication number: 20190382745
    Abstract: Provided are ADAM9 modulating peptides and methods for using the same to modulate ADAM9 biological activities in vitro and/or in vivo, to inhibit ADAM9 biological activities associated with diseases or disorders in subjects, to decrease inflammation, and to inhibit undesirable cellular proliferation, fibrosis, and angiogenesis. In some embodiments, the ADAM9 modulating peptides include modifications of one or more amino acids of the human ADAM9 prodomain amino acid sequence, and in some embodiments the ADAM9 modulating peptides include other modifications such as but not limited to the addition of PEG groups.
    Type: Application
    Filed: January 31, 2019
    Publication date: December 19, 2019
    Applicant: Verra Therapeutics
    Inventors: Marcia L. Moss, Robert Rasmussen, Chris Prince
  • Publication number: 20190345473
    Abstract: Provided are modified isolated ADAM10 modulating peptides and methods of using the same to modulate ADAM10 biological activities, inhibit ADAM10 biological activities associated with diseases, disorders, or conditions in subjects, including but not limited to decreasing inflammation and inhibiting undesirable cell proliferation. In some embodiments, the modified isolated ADAM10 modulating peptides are based on SEQ ID NO: 3 or SEQ ID NO: 4, and in some embodiments include modifications at or near the N-terminal and/or the C-terminal ends of the disclosed peptides as well as substitutions, insertions, and deletions at one or more amino acid positions of the ADAM10 prodomain peptides disclosed herein.
    Type: Application
    Filed: October 2, 2018
    Publication date: November 14, 2019
    Applicant: Verra Therapeutics, Inc.
    Inventors: Marcia L. Moss, Robert Rasmussen, Chris Prince
  • Patent number: 9189822
    Abstract: A process, device and system for mapping usage data from a plurality of utility usage nodes, such as electricity usage meters, to one or more utility distribution nodes, such as a transformer, in which utility usage data collected at a collection device from the plurality of utility usage nodes at predetermined intervals is received, and utility distribution data collected at the collection device from the utility distribution node at the predetermined intervals is likewise received. Aggregate usage data from one or more of the plurality of utility usage nodes is compared to distribution data from the utility distribution node during one or more of the same predetermined intervals to determine, using a computer, which of the plurality of utility usage nodes is connected to the utility distribution node.
    Type: Grant
    Filed: October 19, 2012
    Date of Patent: November 17, 2015
    Assignee: Trilliant Networks, Inc.
    Inventors: Rob Conant, Chris Prince
  • Patent number: 8319658
    Abstract: A process, device and system for mapping usage data from a plurality of utility usage nodes, such as electricity usage meters, to one or more utility distribution nodes, such as a transformer, in which utility usage data collected at a collection device from the plurality of utility usage nodes at predetermined intervals is received, and utility distribution data collected at the collection device from the utility distribution node at the predetermined intervals is likewise received. Aggregate usage data from one or more of the plurality of utility usage nodes is compared to distribution data from the utility distribution node during one or more of the same predetermined intervals to determine, using a computer, which of the plurality of utility usage nodes is connected to the utility distribution node.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: November 27, 2012
    Assignee: Trilliant Networks, Inc.
    Inventors: Rob Conant, Chris Prince
  • Publication number: 20100231413
    Abstract: A process, device and system for mapping usage data from a plurality of utility usage nodes, such as electricity usage meters, to one or more utility distribution nodes, such as a transformer, in which utility usage data collected at a collection device from the plurality of utility usage nodes at predetermined intervals is received, and utility distribution data collected at the collection device from the utility distribution node at the predetermined intervals is likewise received.
    Type: Application
    Filed: March 11, 2010
    Publication date: September 16, 2010
    Inventors: Rob CONANT, Chris PRINCE